IBDEI12I ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,38769,2)
 ;;=^5002471
 ;;^UTILITY(U,$J,358.3,38770,0)
 ;;=E03.9^^148^1939^33
 ;;^UTILITY(U,$J,358.3,38770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38770,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,38770,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,38770,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,38771,0)
 ;;=E06.0^^148^1939^53
 ;;^UTILITY(U,$J,358.3,38771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38771,1,3,0)
 ;;=3^Thyroiditis,Acute
 ;;^UTILITY(U,$J,358.3,38771,1,4,0)
 ;;=4^E06.0
 ;;^UTILITY(U,$J,358.3,38771,2)
 ;;=^2692
 ;;^UTILITY(U,$J,358.3,38772,0)
 ;;=E06.1^^148^1939^54
 ;;^UTILITY(U,$J,358.3,38772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38772,1,3,0)
 ;;=3^Thyroiditis,Subacute
 ;;^UTILITY(U,$J,358.3,38772,1,4,0)
 ;;=4^E06.1
 ;;^UTILITY(U,$J,358.3,38772,2)
 ;;=^119376
 ;;^UTILITY(U,$J,358.3,38773,0)
 ;;=C73.^^148^1939^37
 ;;^UTILITY(U,$J,358.3,38773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38773,1,3,0)
 ;;=3^Malig Neop of Thyroid Gland
 ;;^UTILITY(U,$J,358.3,38773,1,4,0)
 ;;=4^C73.
 ;;^UTILITY(U,$J,358.3,38773,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,38774,0)
 ;;=E10.21^^148^1939^8
 ;;^UTILITY(U,$J,358.3,38774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38774,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,38774,1,4,0)
 ;;=4^E10.21
 ;;^UTILITY(U,$J,358.3,38774,2)
 ;;=^5002589
 ;;^UTILITY(U,$J,358.3,38775,0)
 ;;=E10.9^^148^1939^12
 ;;^UTILITY(U,$J,358.3,38775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38775,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,38775,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,38775,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,38776,0)
 ;;=E11.21^^148^1939^17
 ;;^UTILITY(U,$J,358.3,38776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38776,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,38776,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,38776,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,38777,0)
 ;;=E11.39^^148^1939^18
 ;;^UTILITY(U,$J,358.3,38777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38777,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Ophthalmic Complication NEC
 ;;^UTILITY(U,$J,358.3,38777,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,38777,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,38778,0)
 ;;=E11.43^^148^1939^15
 ;;^UTILITY(U,$J,358.3,38778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38778,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Autonomic Neuropathy
 ;;^UTILITY(U,$J,358.3,38778,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,38778,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,38779,0)
 ;;=E11.59^^148^1939^13
 ;;^UTILITY(U,$J,358.3,38779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38779,1,3,0)
 ;;=3^DM Type 2 w/ Circulatory Complications NEC
 ;;^UTILITY(U,$J,358.3,38779,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,38779,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,38780,0)
 ;;=E11.618^^148^1939^14
 ;;^UTILITY(U,$J,358.3,38780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38780,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Arthropathy NEC
 ;;^UTILITY(U,$J,358.3,38780,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,38780,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,38781,0)
 ;;=E11.621^^148^1939^16
 ;;^UTILITY(U,$J,358.3,38781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38781,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,38781,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,38781,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,38782,0)
 ;;=E11.622^^148^1939^20
 ;;^UTILITY(U,$J,358.3,38782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38782,1,3,0)
 ;;=3^DM Type 2 w/ Skin Ulcer NEC
 ;;^UTILITY(U,$J,358.3,38782,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,38782,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,38783,0)
 ;;=E11.65^^148^1939^19
 ;;^UTILITY(U,$J,358.3,38783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38783,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,38783,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,38783,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,38784,0)
 ;;=E11.9^^148^1939^21
 ;;^UTILITY(U,$J,358.3,38784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38784,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,38784,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,38784,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,38785,0)
 ;;=E13.9^^148^1939^22
 ;;^UTILITY(U,$J,358.3,38785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38785,1,3,0)
 ;;=3^Diabetes Mellitus (Secondary) w/o Complications NEC
 ;;^UTILITY(U,$J,358.3,38785,1,4,0)
 ;;=4^E13.9
 ;;^UTILITY(U,$J,358.3,38785,2)
 ;;=^5002704
 ;;^UTILITY(U,$J,358.3,38786,0)
 ;;=E16.2^^148^1939^29
 ;;^UTILITY(U,$J,358.3,38786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38786,1,3,0)
 ;;=3^Hypoglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,38786,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,38786,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,38787,0)
 ;;=E20.0^^148^1939^34
 ;;^UTILITY(U,$J,358.3,38787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38787,1,3,0)
 ;;=3^Idiopathic Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,38787,1,4,0)
 ;;=4^E20.0
 ;;^UTILITY(U,$J,358.3,38787,2)
 ;;=^5002712
 ;;^UTILITY(U,$J,358.3,38788,0)
 ;;=E20.9^^148^1939^30
 ;;^UTILITY(U,$J,358.3,38788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38788,1,3,0)
 ;;=3^Hypoparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,38788,1,4,0)
 ;;=4^E20.9
 ;;^UTILITY(U,$J,358.3,38788,2)
 ;;=^5002714
 ;;^UTILITY(U,$J,358.3,38789,0)
 ;;=E23.0^^148^1939^31
 ;;^UTILITY(U,$J,358.3,38789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38789,1,3,0)
 ;;=3^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,38789,1,4,0)
 ;;=4^E23.0
 ;;^UTILITY(U,$J,358.3,38789,2)
 ;;=^60685
 ;;^UTILITY(U,$J,358.3,38790,0)
 ;;=E27.1^^148^1939^51
 ;;^UTILITY(U,$J,358.3,38790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38790,1,3,0)
 ;;=3^Primary Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,38790,1,4,0)
 ;;=4^E27.1
 ;;^UTILITY(U,$J,358.3,38790,2)
 ;;=^5002740
 ;;^UTILITY(U,$J,358.3,38791,0)
 ;;=E27.2^^148^1939^1
 ;;^UTILITY(U,$J,358.3,38791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38791,1,3,0)
 ;;=3^Addisonian Crisis
 ;;^UTILITY(U,$J,358.3,38791,1,4,0)
 ;;=4^E27.2
 ;;^UTILITY(U,$J,358.3,38791,2)
 ;;=^263725
 ;;^UTILITY(U,$J,358.3,38792,0)
 ;;=E27.3^^148^1939^23
 ;;^UTILITY(U,$J,358.3,38792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38792,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,38792,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,38792,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,38793,0)
 ;;=E29.1^^148^1939^52
 ;;^UTILITY(U,$J,358.3,38793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38793,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,38793,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,38793,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,38794,0)
 ;;=E55.9^^148^1939^59
 ;;^UTILITY(U,$J,358.3,38794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38794,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,38794,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,38794,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,38795,0)
 ;;=E66.01^^148^1939^38
 ;;^UTILITY(U,$J,358.3,38795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38795,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,38795,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,38795,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,38796,0)
 ;;=E66.8^^148^1939^42
 ;;^UTILITY(U,$J,358.3,38796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38796,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,38796,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,38796,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,38797,0)
 ;;=E66.9^^148^1939^43
 ;;^UTILITY(U,$J,358.3,38797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38797,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,38797,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,38797,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,38798,0)
 ;;=E74.39^^148^1939^35
 ;;^UTILITY(U,$J,358.3,38798,1,0)
 ;;=^358.31IA^4^2
